SCHEMBL12559554

SCHEMBL12559554

[2H]c1cc(C([2H])([2H])[2H])c(N)c(C([2H])([2H])[2H])c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12559544 0.80
SCHEMBL2296346 0.69 ALDH1A1 (0.36)
SCHEMBL15423981 0.67 ALDH1A1 (0.52)
SCHEMBL15423982 0.65 ALDH1A1 (0.39)
SCHEMBL15423979 0.65 CYP3A4 (0.43)
O-Tolylamine SCHEMBL31231107 0.65
SCHEMBL12559550 0.65 ALDH1A1 (0.43)
SCHEMBL11791406 0.65
SCHEMBL12590710 0.63
O-Xylene SCHEMBL3470526 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110160154-A1 SUBSTITUTED PIPERAZINES AUSPEX PHARMACEUTICALS, INC. (US) 2011-06-30 US disclosed
US-20110152303-A1 Chemical Compounds GLAXOSMITHKLINE LLC (US) 2011-06-23 US disclosed
US-20080312247-A1 SUBSTITUTED PIPERAZINES AUSPEX PHARMACEUTICALS, INC. (US) 2008-12-18 US disclosed